Allergy and Immunology, Allergy · Tulsa, OK
NPI
1376524561
Since 2005
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
9311 S Mingo Rd
Tulsa, OK, 74133
Phone (918) 307-1613
Groups this clinician bills Medicare through
Medicare paid, 2024
$909K
44,520 services
Medicare patients, 2024
851
Average age 73
Drug cost, 2024
$7.1M
2,154 prescriptions
Company payments, 2025
$854
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jane T Purser was code J1575 (injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin), 15,825 times for 11 patients. In total Jane T Purser billed 44,520 services in 55 codes, and Medicare paid $909K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-14.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1575 Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin | Office | 15,825 | 11 | $13.41 | $212K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 8,070 | 29 | $35.06 | $283K |
| J2357 Injection, omalizumab, 5 mg | Office | 4,890 | 30 | $29.84 | $146K |
| 95165 Treatment - Miscellaneous | Office | 4,040 | 349 | $9.54 | $39K |
| 95117 Treatment - Miscellaneous | Office | 1,262 | 347 | $7.30 | $9,210 |
| 95004 Test - Miscellaneous | Office | 1,171 | 29 | $2.42 | $2,838 |
| 95044 Test - Miscellaneous | Office | 967 | 15 | $3.13 | $3,029 |
| 95024 Test - Miscellaneous | Office | 338 | 21 | $5.57 | $1,882 |
| 95115 Treatment - Miscellaneous | Office | 319 | 99 | $6.32 | $2,016 |
| 96370 Intravenous Infusion, Hydration | Office | 303 | 22 | $11.60 | $3,515 |
| 99214 Office E&M - Established | Office | 250 | 226 | $84.09 | $21K |
| 96372 Injection Administration | Office | 231 | 45 | $10.04 | $2,319 |
| 96366 Intravenous Infusion, Hydration | Office | 210 | 22 | $14.64 | $3,074 |
| 96369 Intravenous Infusion, Hydration | Office | 177 | 22 | $98.65 | $17K |
| 99215 Office E&M - Established | Office | 155 | 118 | $127.62 | $20K |
By year: 2022 $860K for 46,516 services; 2023 $884K for 47,149 services; 2024 $909K for 44,520 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jane T Purser prescribed most often to Medicare patients was Montelukast Sodium, with 363 prescriptions and refills. In total Jane T Purser wrote 2,154 Medicare prescriptions that cost $7.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 363 | 961 | 117 | $9,385 |
| Breo Ellipta Fluticasone/Vilanterol | 148 | 236 | 46 | $89K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 109 | 177 | 32 | $106K |
| Prednisone Generic | 106 | 107 | 86 | $235 |
| Ipratropium Bromide Generic | 84 | 129 | 44 | $3,212 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 73 | 76 | 55 | $1,396 |
| Azelastine Hcl Generic | 67 | 123 | 28 | $2,849 |
| Azithromycin Generic | 66 | 83 | 39 | $774 |
| Berinert C1 Esterase Inhibitor | 65 | 65 | Under 11 | $1.4M |
| Epinephrine Generic | 62 | 63 | 52 | $11K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 51 | 51 | 37 | $602 |
| Azelastine-Fluticasone Azelastine/Fluticasone | 50 | 81 | 18 | $8,363 |
| Dupixent Pen Dupilumab | 44 | 44 | Under 11 | $174K |
| Fluticasone Propionate Generic | 41 | 94 | 18 | $840 |
| Mometasone Furoate Generic | 39 | 67 | 16 | $2,063 |
Brand drugs: 861 claims; generic drugs: 1,293 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jane T Purser $854 ($854 in general payments such as food, travel and fees) from 11 companies. The largest payer was Genentech USA, Inc. with $195.
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. ROG.SW | 6 | $195 |
| Genentech, Inc. ROG.SW | 3 | $180 |
| BioCryst US Sales Co., LLC | 4 | $155 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 3 | $70.34 |
| CSL Behring CSL.AX | 2 | $54.7 |
| Galderma Laboratories, L.P. GALD.SW | 2 | $48.25 |
| Pharming Healthcare, Inc. | 2 | $45.87 |
| Pfizer Inc. PFE | 2 | $42.56 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $22.12 |
| Optinose US, Inc. | 1 | $21.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.